Literature DB >> 25004405

Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.

Debby Basu1, Peng Xiao2, Zachary Ende3, Alfred Bere4, William J Britt5, Joseph Mulenga6, William Kilembe7, Susan A Allen8, Cynthia A Derdeyn9, Eric Hunter10.   

Abstract

We have previously shown that HIV-1 superinfected Zambian seroconverters mount low binding and neutralizing antibody responses to their primary HIV-1 infecting virus, which could increase susceptibility to re-infection. Here, we investigated if antibody-dependent cellular cytotoxicity (ADCC), a process by which virus-infected cells are killed, was also reduced. Superinfected individuals exhibited low ADCC activity compared to non-superinfected individuals, but similar levels of CMV-reactive binding antibodies, suggesting superinfected individuals are capable of generating and maintaining virus-specific antibodies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADCC; HIV dual infection; HIV-1 ADCC; HIV-1 superinfection

Mesh：

Substances：

Year:  2014        PMID： 25004405      PMCID： PMC4125417          DOI： 10.1016/j.virol.2014.06.016

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  22 in total

1.  Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.

Authors:  D N Forthal; G Landucci; E S Daar
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

Authors:  V Raúl Gómez-Román; Ruth H Florese; L Jean Patterson; Bo Peng; David Venzon; Kris Aldrich; Marjorie Robert-Guroff
Journal:  J Immunol Methods       Date:  2005-11-28       Impact factor: 2.303

3.  HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

Authors:  L L Baum; K J Cassutt; K Knigge; R Khattri; J Margolick; C Rinaldo; C A Kleeberger; P Nishanian; D R Henrard; J Phair
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.

Authors:  M Kramski; A Schorcht; A P R Johnston; G F Lichtfuss; S Jegaskanda; R De Rose; I Stratov; A D Kelleher; M A French; R J Center; A Jaworowski; S J Kent
Journal:  J Immunol Methods       Date:  2012-07-24       Impact factor: 2.303

5.  Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Authors:  Colleen S Kraft; Debby Basu; Paulina A Hawkins; Peter T Hraber; Elwyn Chomba; Joseph Mulenga; William Kilembe; Naw H Khu; Cynthia A Derdeyn; Susan A Allen; Olivier Manigart; Eric Hunter
Journal:  Retrovirology       Date:  2012-03-20       Impact factor: 4.602

6.  Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.

Authors:  Donald N Forthal; Gary Landucci; Bhavna Chohan; Barbra A Richardson; R Scott McClelland; Walter Jaoko; Catherine Blish; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

Review 7.  New paradigms for functional HIV-specific nonneutralizing antibodies.

Authors:  Don Forthal; Thomas J Hope; Galit Alter
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

Review 8.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

9.  Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

Authors:  Georgia D Tomaras; Guido Ferrari; Xiaoying Shen; S Munir Alam; Hua-Xin Liao; Justin Pollara; Mattia Bonsignori; M Anthony Moody; Youyi Fong; Xi Chen; Brigid Poling; Cindo O Nicholson; Ruijun Zhang; Xiaozhi Lu; Robert Parks; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Peter B Gilbert; Jerome H Kim; Nelson L Michael; David C Montefiori; Barton F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-09       Impact factor: 11.205

10.  HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.

Authors:  Debby Basu; Colleen S Kraft; Megan K Murphy; Patricia J Campbell; Tianwei Yu; Peter T Hraber; Carmela Irene; Abraham Pinter; Elwyn Chomba; Joseph Mulenga; William Kilembe; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  Retrovirology       Date:  2012-09-20       Impact factor: 4.602
View more
  5 in total

Review 1.  Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.

Authors:  Yang Gao; Wen Tian; Xiaoxu Han; Feng Gao
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

2.  HIV-1 Superinfection Resembles Primary Infection.

Authors:  Daniel J Sheward; Roman Ntale; Nigel J Garrett; Zenda L Woodman; Salim S Abdool Karim; Carolyn Williamson
Journal:  J Infect Dis       Date:  2015-03-09       Impact factor: 5.226

3.  Reduced frequency of HIV superinfection in a high-risk cohort in Zambia.

Authors:  Evonne Woodson; Debby Basu; Hope Olszewski; Jill Gilmour; Ilene Brill; William Kilembe; Susan Allen; Eric Hunter
Journal:  Virology       Date:  2019-06-15       Impact factor: 3.616

4.  Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women.

Authors:  Keshet Ronen; Adam S Dingens; Susan M Graham; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Julie Overbaugh
Journal:  EBioMedicine       Date:  2017-04-07       Impact factor: 8.143

5.  Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters.

Authors:  Mariam Aziz; Fareeha Mahmood; Mariana Mata; Helen G Durkin; Chenglong Liu; Ruth M Greenblatt; Marek Nowicki; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Linda L Baum
Journal:  J AIDS Clin Res       Date:  2015-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.